华体会手机版app官网下载|华体会体育APP官方入口

登录 | 注册    关注公众号  
搜索
 >  其他蛋白>CTLA-4 >EP-117

B7-2 [Biotinylated] : CTLA-4 Inhibitor Screening ELISA Kit

For research use only.

IDComponentsSize
EP117-C01High-bind Plate1 plate
EP117-C02Human CTLA-410 μg
EP117-C03Biotinylated Human B7-265 μg
EP117-C04Anti-CTLA-4 Neutralizing Antibody20 μg
EP117-C05Streptavidin-HRP10 μg
EP117-C06Coating Buffer12 mL
EP117-C0710xWashing Buffer 50 mL
EP117-C08Blocking Buffer50 mL
EP117-C09Substrate Solution24 mL
EP117-C10Stop Solution7 mL

Background/背景

Cytotoxic T lymphocyte associated ANTIgen-4 (CTLA-4), also known as CD152, is a kind of leukocyte differentiation antigen and a transmembrane receptor on T cells, sharing B7 ligand with CD28. The binding of CTLA-4 with B7 induces T cells to be non-reactive and participates in the negative regulation of immune response. The recombinant CTLA-4 Ig can effectively and specifically inhibit cellular and humoral immune responses in vivo and in vitro, and has significant therapeutic effects on transplant rejection and various autoimmune diseases with very low toxicity. It is considered as a promising new immunosuppressive drug at present.

Application/应用

This kit is developed for screening for inhibitors of human CTLA-4 binding to human B7-2.

It is for research use only.

Reconstitution/重构方法

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

Storage/存储

The unopened kit is stable for 12 months from the date of manufacture if stored at 2°C to 8°C. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

Assay Principles/原理

This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new CTLA-4 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human B7-2 to immobilized human CTLA-4 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated B7-2 protein, a human CTLA-4 protein, an anti-CTLA-4 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human CTLA-4.

b) Add your molecule of interest to the tests.

c) Add human B7-2-Biotin to bind the coated human CTLA-4.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

Finally, the ability of your compound to inhibit B7-2: CTLA-4 binding will be determined by comparing OD readings among different experimental groups.

 

Typical Data/典型数据

Biotinylated Human ELISA

B7-2 [BIOTINYLATED]: CTLA-4 BINDING IN THE ABSENCE OF INHIBITORS
Immobilized human CTLA-4 protein at 0.2 μg/mL (100 μL/well) can bind biotinylated human B7-2 with a linear range of 0.01-20 μg/mL when detected by Streptavidin-HRP. Background was subtracted from data points before curve fitting (QC tested).

Protocol

Biotinylated Human SPR

INHIBITION OF B7-2 [BIOTINYLATED]: CTLA-4 BINDING BY ANTI-CTLA-4 NEUTRALIZING ANTIBODY
Serial dilutions of Anti-CTLA-4 Neutralizing antibody (Catalog # EP117-C04) (1:1 serial dilution, from 10 μg/mL to 0.01μg/mL) was added into CTLA-4: Biotinylated B7-2 binding reactions. The assay was performed according to the protocol described below. Background was subtracted from data points prior to log transformation and curve fitting (QC tested).

Protocol

前沿进展

 
 
货号/价格
开发建议
文档
联系电话:
400-682-2521(全国)
010-53681107(北京)
021-31168505(上海)
运输方式
订单邮箱:
order.cn@acrobiosystems.com
技术支持邮箱:
tech.cn@acrobiosystems.com
CTLA-4靶点信息
英文全称:Cytotoxic T-Lymphocyte-Associated Antigen 4
中文全称:细胞毒性T淋巴细胞相关抗原4
种类:Homo sapiens
上市药物数量:1详情
临床药物数量:48详情
最高研发阶段:批准上市
前沿进展

消息提示

请输入您的联系方式,再点击提交!

确定